《Stem Cells Translational Medicine》雜志的最新年發文量為88篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在細胞與組織工程領域的學術影響力。
該刊聚焦于醫學-細胞與組織工程領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 較慢,6-12周 。
Stem Cells Translational Medicine 雜志發文統計
文章名稱引用次數
- Concise Reviews: Cancer Stem Cell Targeted Therapies: Toward Clinical Success33
- Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial33
- Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial32
- Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise31
- Concise Review: Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era?31
- Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions30
- Concise Review: Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells27
- Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair26
- Mesenchymal Stem Cell-Derived Extracellular Vesicles as Therapeutics and as a Drug Delivery Platform26
- Systematic Comparison of Retinal Organoid Differentiation from Human Pluripotent Stem Cells Reveals Stage Specific, Cell Line, and Methodological Differences21
國家/地區發文量
- USA195
- CHINA MAINLAND57
- Spain45
- Italy33
- England28
- Canada27
- GERMANY (FED REP GER)25
- Japan25
- Australia16
- France16
